Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

Indian pharma

  1. Home>
  2. News>
  3. Indian pharma>
  4. Page 7

How to Verify the Quality of Indian Generic Medicines: A Buyer’s Guide

  • Post published:June 6, 2026
  • Post category:Knowledge

Indian generic medicines have earned global recognition for making high-quality healthcare affordable. However, with over 10,000 manufacturers across the country, quality standards can vary. This guide explains exactly how to…

Continue Reading How to Verify the Quality of Indian Generic Medicines: A Buyer’s Guide

India’s Semaglutide Generic Boom Reshapes GLP-1 Market in 2026

  • Post published:June 5, 2026
  • Post category:News

On March 20, 2026, Novo Nordisk's patent on semaglutide expired in India, triggering one of the most significant transformations in the country's pharmaceutical history. Within weeks, more than 40 Indian…

Continue Reading India’s Semaglutide Generic Boom Reshapes GLP-1 Market in 2026

How to Choose a Reliable Indian Generic Medicine Supplier: A Complete Buyer’s Guide

  • Post published:June 4, 2026
  • Post category:Knowledge

🔬 How to Choose a Reliable Indian Generic Medicine Supplier: A Complete Buyer’s Guide India supplies approximately 20% of the world’s generic medicines by volume, exporting over USD 50 billion…

Continue Reading How to Choose a Reliable Indian Generic Medicine Supplier: A Complete Buyer’s Guide

US 100% Pharma Tariff Spares Indian Generics — What Buyers and Exporters Need to Know

  • Post published:May 28, 2026
  • Post category:News

The United States imposed a sweeping 100% tariff on patented pharmaceutical imports on April 2, 2026, under Section 232 of the Trade Expansion Act. However, generic medicines — which make…

Continue Reading US 100% Pharma Tariff Spares Indian Generics — What Buyers and Exporters Need to Know
  • Go to the previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • Go to the next page

Recent Posts

  • India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%
    July 14, 2026/
    0 Comments
  • Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide
    July 5, 2026/
    0 Comments
  • Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026
    July 4, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%
  • Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide
  • Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026
  • India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026
  • India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve